3 Reasons Monsanto Company's Stock Could Fall

The leading sustainable agriculture company could face several short and long-term obstacles that cause its stock to fall.

Aug 23, 2014 at 9:40AM

While Monsanto Company (NYSE:MON) is often the source of debate and controversy, there's no disputing the tremendous growth the company has delivered to shareholders in the last decade.

MON Chart

MON data by YCharts

Investors may still be optimistic about the company's future with share prices approaching levels last witnessed before the Great Recession. Growth initiatives are in place, share buybacks are being accelerated, and new products are launching every year. What's not to like? Well, as every Foolish investor knows, stocks can go up or down for various reasons. Let's take a look at three reasons Monsanto Company's stock could fall in the next several months or years.

1. Unsustainable share buybacks

On the same day the failed $40 billion merger with rival Syngenta was announced, Monsanto Company management pivoted by announcing a $4.5 billion debt issuance. What would be the main use of the money, you ask? While some of the net proceeds would fund general corporate needs, the bulk of the funds would be thrown at a $6 billion accelerated share repurchase program. The accelerated initiative is actually part of a larger $10 billion share repurchase program that will take place over a two year period.

Plenty of companies have been taking advantage of low borrowing costs to fund share repurchases with debt, but "everyone else is doing it" is rarely a good excuse. Despite more than doubling the long-term debt on its balance sheet, Monsanto Company can comfortably swallow more debt (it's targeting a net debt to EBITDA ratio of 1.5 for its 2015 fiscal year). However, using debt in this way creates a false sense of health for individual companies and the broader stock market.

Let's view an example from Monsanto Company's third quarter in 2014 compared to the same period last year.




% Change

Net income

$858 million

$909 million






Outstanding shares

529.8 million

540 million


Source: SEC filings.

In the quarterly comparison, net income actually decreased 5.7%, but EPS only decreased 3.5% thanks to roughly 10 million fewer shares. Now consider that the share repurchase program will gobble up over 51 million outstanding shares in the next six to 12 months and 86 million outstanding shares total in the next two years. In other words, assuming Monsanto Company registers flat growth on the bottom line in 3Q 2015, EPS will still "grow" by at least 11%.

While that may appear as a great reason for Monsanto Company stock to rise, it's unsustainable in the long term. Larger consequences could arrive from dozens of the largest companies artificially boosting their EPS with the same practice, especially considering the S&P 500 has a CAPE of 26.3 -- higher than all but three periods in history.

2. Falling corn segment sales

Farmers across the United States are gearing up for record harvests of corn and soybeans this fall. The U.S. Department of Agriculture expects over 14 billion bushels of corn and 3.82 billion bushels of soybeans to be grown and plucked from soils when all is said and done. Yields of 167.4 bushels per acre and 45.4 bushels per acre, respectively, will also be records. That would appear to be great news for a seed and trait specialist such as Monsanto Company, but those lofty expectations have come with mixed results. 

In the third quarter compared to the same period last year, Monsanto Company witnessed a $256 million, or 16%, decrease in corn seed and trait sales that offset a $158 million, or 24%, increase in soybean seed and trait sales. In fact, the fall in corn sales more than offset gains in the company's remaining four segments in the Seeds and Genomics and Agricultural Productivity Division. Results have been better when looking at the previous nine month period comparison, but corn sales are still down on lower volumes. Is competition catching up to the company's flagship segment?

3. Increased exposure to emerging markets

A key pillar in Monsanto Company's growth strategy includes expansion into emerging markets -- and for good reason. Take a look at how sales were distributed across the following worldly breadbaskets in 2013:


Monsanto Company 2013 Sales

North America

$9.13 billion

Europe, Africa, Middle East

$2.04 billion

South America

$2.67 billion


$806 million



Total Sales

$14.9 billion

*Excludes Lawn and Garden segment. Source: SEC filings.

New growth will come with new risks, however. On the third quarter conference call, management stated that currency conversions will result in a $0.15-$0.20 reduction in EPS in 2014. Growing the company's exposure to emerging markets will be great news in the long term by decreasing its dependence on farmers in the United States and Europe, but there will be some headwinds along the way.

Foolish bottom line

Overall there is a lot to like about the short- and long-term direction for Monsanto Company. Management has an eye on product development, organic growth, and strategic acquisitions. Of course, responsible investors will look at both the opportunities and risks facing their companies. Share buybacks that artificially increase EPS, falling corn seed and trait sales, and increased exposure to emerging markets with new risks could all cause Monsanto Company's stock to fall. At the very least, investors should be aware of the obstacles facing the company. 

Top dividend stocks for the next decade

The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolioCAPS pageprevious writing for The Motley Fool, or his work with SynBioBeta to keep up with developments in the synthetic biology industry.

The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information